The Weekly Litigation News Digest is now live. Subscribe now

IP Verse

Acorda Therapeutics competitive analysis

Loading summary...

Latest patents of Acorda Therapeutics opposed by its competitors

Explore Acorda Therapeutics's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Nov 13, 2025
Patent NumberPublication DateTitleTotal Oppositions
EP2377536
Aug 17, 2022Methods Of Using Sustained Release Aminopyridine Compositions3

Latest PTAB cases involving Acorda Therapeutics

Discover the latest PTAB cases involving Acorda Therapeutics, highlighting their recent legal challenges and patent disputes.

Last updated on: Nov 13, 2025
Proceeding NumberFiling DatePetitionerRespondentStatus

Get alerts for PTAB Cases involving Acorda Therapeutics

IPR2015-01857Sep 3, 2015COALITION FOR AFFORDABLE DRUGS ADROCAACORDA THERAPEUTICSFinal Written Decision
IPR2015-01858Sep 3, 2015COALITION FOR AFFORDABLE DRUGS ADROCAACORDA THERAPEUTICSFinal Written Decision
IPR2015-01850Sep 2, 2015COALITION FOR AFFORDABLE DRUGS ADROCAACORDA THERAPEUTICSFinal Written Decision
IPR2015-01853Sep 2, 2015COALITION FOR AFFORDABLE DRUGS ADROCAACORDA THERAPEUTICSFinal Written Decision
IPR2015-00817Feb 27, 2015COALITION FOR AFFORDABLE DRUGS ADROCAACORDA THERAPEUTICSInstitution Denied
IPR2015-00720Feb 10, 2015COALITION FOR AFFORDABLE DRUGS ADROCAACORDA THERAPEUTICSInstitution Denied

Peer Comparison New

IP litigation analysis comparing Acorda Therapeutics with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Nov 13, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
ACORDA THERAPEUTICS - 3 - 6
ACTAVIS GROUP PTC EHF1 - - -
COALITION FOR AFFORDABLE DRUGS ADROCA - - 6 -
NEURAXPHARM ARZNEIMITTEL4 - - -